ANGO Financial Facts
Net income: 1.3MTotal operating expenses: 41.46M
See Full Income Statement
Total current liabilities: 65.43M
Current portion of long-term debt: 17.5M
See Full Balance Sheet
AngioDynamics (ANGO) Earnings
|
Expand Research on ANGO
| Next EPS Date | 10/1/26 | EPS Growth Rate | -10.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +40.3% | Revenue Growth Rate | +6.3% |
| Average % Move 1-Wk after EPS | +2.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/1/26  |
Q127 | N/A | -$0.11 | N/A | N/A | $80.5M | = | N/A | N/A | ||
| 7/14/26 | Q426 | -$0.07 | -$0.09 | +$0.02 | $86.61M | $80.24M | = |  | | Details | |
| 4/2/26 | Q326 | -$0.07 | -$0.09 | +$0.02 | $78.42M | $76.71M | = | | | Details | |
| 1/6/26 | Q226 | $0.00 | -$0.10 | +$0.10 | $79.4M | $76.3M | = | | | Details | |
| 10/2/25 | Q126 | -$0.10 | -$0.12 | +$0.02 | $75.7M | $72.7M | = | | | Details | |
| 7/15/25 | Q425 | -$0.03 | -$0.12 | +$0.09 | $80.2M | $74.27M | = | | | Details | |
| 4/2/25 | Q325 | $0.03 | -$0.11 | +$0.14 | $72M | $70.57M | = | | | Details | |
| 1/8/25 | Q225 | -$0.04 | -$0.11 | +$0.07 | $73M | $70.93M | = | | | Details |
